Harnessing the power of hepatitis B screening programmes: the I REACH OUT model
James Lok(King's College Hospital), Kosh Agarwal(King's College - North Carolina), Mark Gillyon-Powell(NHS England), Chari Cohen(Hepatitis B Foundation), Su Wang(Rutgers, The State University of New Jersey), Claire Martin(King's College Hospital)
Cited by 0
Related Papers
ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin for Hepatitis C with Cirrhosis
|New England Journal of Medicine|2014|877
Zika Virus NS4A and NS4B Proteins Deregulate Akt-mTOR Signaling in Human Fetal Neural Stem Cells to Inhibit Neurogenesis and Induce Autophagy
|Cell stem cell|2016|565
Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference‡
|Journal of Hepatology|2019|364